- Home
- / Neuronetics
Neuronetics
Stock Price
$1
2024-10-29
Market Capitalization
$30 M
2024-10-28
Revenue
$149.2 M
FY, 2025
Neuronetics Summary
Company Summary
- Overview
- Neuronetics is a medical technology company that designs and develops therapies for neurohealth disorders. It offers NeuroStar Advanced Therapy that uses transcranial magnetic stimulation (TMS) for neuromodulation depression.
- Type
- Public
- Status
- Active
- Founded
- 2003
- HQ
- Malvern, PA, US | view all locations
- Website
- https://neurostar.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Cory Anderson, SVP, R&D and Clinical
Todd Cushman, SVP, Business Development
Steve Furlong, EVP, CFO & Treasurer
LocationsView all
1 location detected
Malvern, PA HQ
United States
3222 Phoenixville Pike
Neuronetics Financials
Summary Financials
- Revenue (Q1, 2026)
- $34.5M
- Gross profit (Q1, 2026)
- $16.2M
- Net income (Q1, 2026)
- ($10.8M)
- Cash (Q1, 2026)
- $13.2M
- EBIT (Q1, 2026)
- ($9.0M)
- Enterprise value
- $102.2M